Scilex Holding Company

Research Scilex Holding Company (SCLX) on Bullrun: market cap USD 54.86M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSCLX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-General
• CurrencyUSD
• Market capUSD 54.86M
• Financial periodFY2025
• RevenueUSD 30.25M
• Revenue growth-46.5%
• Net income-USD 374.05M
• Free cash flowUSD 3.68M
• Gross margin415.8%

Valuation Snapshot

latest market cap is USD 54.86M.

About Scilex Holding Company

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults;

Frequently asked questions

What is Scilex Holding Company's market cap?

Scilex Holding Company's market capitalization is USD 54.86M.

What does Scilex Holding Company do?

Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.